Risk Prediction Models for Kidney Disease

Risk prediction models for kidney disease integrate clinical, biochemical and computational methods to forecast the onset, progression and adverse outcomes of renal impairment. Traditional risk scores and equations—using variables such as age, sex, blood pressure, diabetes status, estimated glomerular filtration rate and albuminuria—have provided acceptable discrimination and calibration in diverse populations. However, these models often lack considerations for multimorbidity, frailty and ethnic diversity. Recent advances harness machine learning, artificial intelligence and digital twin approaches to analyse large-scale electronic health records, biomarkers and imaging data. These methods aim to deliver personalised risk estimates, support clinical decision-making, optimise timing of referrals and trial enrolment, and ultimately improve patient outcomes on a global scale.

Research from Nature Portfolio

Recent studies have demonstrated the potential of machine learning algorithms to enhance risk stratification in chronic kidney disease. A 2022 report assessed five classifiers—including logistic regression, naïve Bayes and random forest—on longitudinal data from a cohort of patients with established renal impairment. Several models matched or exceeded the performance of standard equations in predicting end-stage renal disease within five years, offering improved sensitivity for early risk detection. An earlier foundational study applied artificial intelligence techniques to predict progression of diabetic kidney disease by analysing electronic medical records and temporal feature patterns. The model achieved over 70 per cent accuracy in forecasting six-month deterioration and linked predicted progression to long-term need for renal replacement therapy. These approaches illustrate how AI-driven analytics can translate routinely collected clinical data into actionable risk estimates.

Risk Prediction Models for Kidney Disease publication trend

The graph below shows the total number of articles in risk prediction models for kidney disease across all publications each year (not limited to Nature Index journals).

Technical terms

Chronic Kidney Disease (CKD): A progressive condition characterised by gradual loss of renal function over time.

End-stage Renal Disease (ESRD): The final stage of CKD requiring renal replacement therapy such as dialysis or transplantation.

Estimated Glomerular Filtration Rate (eGFR): A calculated index of kidney filtration capacity based on serum creatinine and patient demographics.

Albumin-to-Creatinine Ratio (ACR): A urinary biomarker measuring albumin excretion relative to creatinine, indicating glomerular damage.

Machine Learning: Computational techniques that enable models to learn patterns from data for predictive analytics.

Digital Twin: A virtual representation of an individual’s physiological state used to simulate and predict disease trajectories.

References

1. A digital twin model incorporating generalized metabolic fluxes to identify and predict chronic kidney disease in type 2 diabetes mellitus. npj Digital Medicine (2024).
2. Representation of multimorbidity and frailty in the development and validation of kidney failure prognostic prediction models: a systematic review. BMC Medicine (2024).
3. Machine learning to predict end stage kidney disease in chronic kidney disease. Scientific Reports (2022).
4. Artificial intelligence predicts the progression of diabetic kidney disease using big data machine learning. Scientific Reports (2019).
5. Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease. Diabetologia (2021).